EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Nanomaterials-mediated adenosine pathway inhibition for strengthening cancer immunotherapy

Wenhu Zhu, Fei Wu, Zhanhong Qiao, Ming Zhao, Haiyang Hu

Theranostics · 2025

DOI: 10.7150/thno.108931 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Theranostics, 2025. Verfasst von Wenhu Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang, 110016, P. R. China. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, Adenosine, Nanostructures. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNeoplasmsAdenosineNanostructuresHumansTumor MicroenvironmentAnimalsReceptors, Purinergic P1Signal TransductionNanomedicine

Stichwörter der Autor:innen

adenosineadenosine pathway inhibitorscancer immunotherapyimmunosuppressionnanomaterials

Substanzen

AdenosineReceptors, Purinergic P1

Autor:innen und Institutionen

  • Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang, 110016, P. R. China.

Zitieren

APA

Zhu, W., Wu, F., Qiao, Z., Zhao, M., & Hu, H. (2025). Nanomaterials-mediated adenosine pathway inhibition for strengthening cancer immunotherapy. Theranostics. https://doi.org/10.7150/thno.108931

Vancouver

Zhu W, Wu F, Qiao Z, Zhao M, Hu H. Nanomaterials-mediated adenosine pathway inhibition for strengthening cancer immunotherapy. Theranostics. 2025. doi:10.7150/thno.108931

BibTeX
@article{Zhu2025,
  author = {Zhu, Wenhu and Wu, Fei and Qiao, Zhanhong and Zhao, Ming and Hu, Haiyang},
  title = {Nanomaterials-mediated adenosine pathway inhibition for strengthening cancer immunotherapy},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.108931}
}
Kostenlos starten →